Ultragenyx Pharmaceutical Inc. (RARE)
Q4 2018 Earnings Conference Call
February 19, 2019 5:00 PM ET
Company Participants
Danielle Keatley — Senior Director-Investor Relations and Corporate Communications
Emil Kakkis — Chief Executive Officer and President
Vlad Hogenhuis — Chief Operating Officer
Shalini Sharp — Chief Financial Officer
Conference Call Participants
Carmen Augustine — JPMorgan
Gena Wang — Barclays
Joseph Schwartz — SVB Leerink
Chris Raymond — Piper Jaffray
Maurice Raycroft — Jefferies
Vincent Chen — Bernstein
Arlinda Lee — Canaccord
Jeff Hung — Morgan Stanley
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the